Skip to content

White House

Dr. Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services, is pictured during a news conference on April 16. Oz has signaled that his agency had something in the works on Medicare pricing for popular GLP-1 medications used to treat obesity and diabetes, even though the list of 2027 Medicare price negotiations included those medications.

Trump’s approach to lowering drug costs is raising questions